GBA1 and Parkinson disease: Furthermore, treatment with thapsigargin, an inhibitor of the ER-Ca2+ ATPase, induces an elevated release of Ca2+ in fibroblasts from GD1 patients and PD patients carrying GBA1 mutations (Kilpatrick et al., 2016).